Wallsti
Macro Next
Meme ranking

LQDA

Liquidia Corporation · Healthcare · Drug Manufacturers - Specialty & Generic
TECHSellMABuyZACKSStrong Sell R500#49 today TARGET+73%
$28.64 +2.32% today · -58.15% 1W
Oct 2 close or latest
PreviewWhy it's moving

Outperforming without a clear catalyst yet

Assembled from Wallsti's own signals.

After each kind of event

EventEvents1 day1 week1 month1 quarter
Any day 1,255 +0.2%#122 H +0.9%#73 H +4.8%#31 H +12.5%#24 M
Big drop Sep 29 (-3.9% or worse) 62 -0.1%#296 H +1.6%#166 H +11.2%#38 H +20.6%#65 M
Big gain (+4.9% or better) 61 +0.4%#186 H +1.2%#196 H +4.7%#127 H +11.2%#105 M
Earnings beat 8 +0.6%#238 M +0.7%#221 M +9.9%#174 M +41.5%#63 M
Earnings miss 12 +3.7%#42 M +9.0%#31 M -6.7%#203 M +13.1%#102 M
52-week high 14 +0.8%#85 M +2.2%#193 M +3.7%#213 M +2.3%#217 M
52-week low — — — — —
Crossed above 200-day avg 10 -1.0%#344 M +1.2%#192 M +12.0%#202 M +6.3%#162 L
Crossed below 200-day avg Sep 30 11 +2.1%#179 M +1.1%#199 M +25.0%#157 M +6.3%#198 L
RSI oversold Sep 30 5 +2.1%#224 L +10.3%#60 L +17.3%#171 L +73.2%#182 L
RSI overbought 21 +0.7%#200 H +0.6%#198 H +6.7%#140 H -1.0%#276 M
Reddit spike 1 -11.2%– -9.2%– -29.3%– -41.4%–
Analyst upgrade — — — — —
Analyst downgrade — — — — —
Insider buy 1 -1.6%– -0.2%– +19.5%– +10.7%–
Insider unplanned sale 17 -0.7%#27 M -0.1%#22 M +7.8%#8 M +37.9%#6 L

Median gain from the close of the session the event was known, over each holding period; #rank among the S&P 500 stocks after the same kind of event (#1 = best). "Big" is LQDA's own: its worst / best 10% of days over the prior 2 years. Highlighted: happening in the latest session.

Insider unplanned sale

An insider's sale outside a pre-arranged 10b5-1 plan; entry the session after its SEC filing.

HoldingEventsMedian (likely range)ConfidenceRankUpvs SPYRange of outcomes (worst · 25–75% · median · best)vs S&P 500 stocks (their medians)
1 day 17 ≈15 indep. -0.72% (-2.2 to +1.6) Medium #27 of 34 35% -1.22%
1 week 17 ≈15 indep. -0.05% (-2.5 to +1.2) Medium #22 of 34 35% -2.68%
1 month 16 ≈9 indep. +7.75% (+3.9 to +19.9) Medium #8 of 33 75% +2.61%
1 quarter 13 ≈4 indep. +37.94% (+15.0 to +87.4) Low #6 of 28 85% +36.28%

Range of outcomes: all of LQDA's unplanned insider sales in the past 5 years, from the worst to the best result over each holding period; the box holds the middle half, the tick is the median. A wide box means the median alone says little. Hover the median for the average.

Insider unplanned sale by trend

When it happenedEvents1 day1 week1 month1 quarter
Long trendAbove its 200-day avg 17 -0.7%M vs +0.2% -0.1%M vs +0.6% +7.8%M vs +3.2% +37.9%L vs +7.3%
Below its 200-day avg now — — — — —
Medium trendAbove its 50-day avg 12 -1.2%M vs +0.3% -0.7%M vs +1.1% +9.7%M vs +4.9% +20.3%L vs +7.1%
Below its 50-day avg now 5 +2.0%L vs +0.1% -0.1%L vs +0.4% +7.8%– vs +3.5% +87.4%– vs +19.7%
Short trendAbove its 20-day avg 14 -0.4%M vs 0.0% -0.1%M vs +0.4% +8.7%L vs +5.9% +36.4%L vs +10.1%
Below its 20-day avg now 3 -3.4%L vs +0.3% -1.6%L vs +1.4% -7.7%– vs +2.1% +37.9%– vs +18.0%

The same event split by where LQDA stood against its 200-, 50- and 20-day averages when it happened (a dip in an uptrend vs a falling knife); "vs" is the plain any-day median in that trend; "now" marks where it stands today. Splitting halves the evidence, so watch the confidence letters: H / M / L.

Latest unplanned insider sales

EventEntry1 day1 week1 month1 quarter
Sep 14, 2026 Sep 16 @ $68.45 Raman Singh (Director), $1,179,453 -0.1% -1.4% … …
Aug 19, 2026 Aug 20 @ $71.05 Rajeev Saggar (Chief Medical Officer), $5,972,206 -3.4% -1.6% -6.5% …
Jul 21, 2026 Jul 23 @ $89.03 Stephen M Bloch (Director), $6,285,250 -3.2% -2.5% -22.9% …
Jul 1, 2026 Jul 7 @ $81.23 Stephen M Bloch (Director), $1,986,695 -2.2% -5.8% +9.7% …
Jun 22, 2026 Jun 25 @ $76.92 Stephen M Bloch (Director), $7,573,704 +1.6% +2.6% +9.8% -7.8%
Jun 11, 2026 Jun 15 @ $71.80 Stephen M Bloch (Director), $26,634,789 -5.3% +3.1% +4.8% -8.5%
Jun 3, 2026 Jun 4 @ $62.54 Arthur S Kirsch (Director), $1,731,300 -1.1% +14.5% +29.9% +9.7%
May 21, 2026 May 27 @ $62.03 Raman Singh (Director), $1,773,436 0.0% -10.2% +26.0% +15.0%
May 11, 2026 May 14 @ $59.30 Stephen M Bloch (Director), $16,016,775 -4.0% +4.5% +21.1% +25.5%
Apr 13, 2026 Apr 15 @ $40.12 Sarah Krepp (Chief Human Resource Officer), $174,852 +3.2% -7.6% +47.8% +87.6%
Mar 27, 2026 Mar 31 @ $37.74 Stephen M Bloch (Director), $2,533,766 -0.7% +1.2% +3.9% +110.2%
Mar 13, 2026 Mar 18 @ $36.63 Rajeev Saggar (Chief Medical Officer), $1,283,834 +2.0% -0.1% +7.8% +87.4%
Nov 5, 2025 Nov 10 @ $27.26 Rajeev Saggar (Chief Medical Officer), $1,927,287 +1.9% +4.2% +19.9% +47.4%
Sep 15, 2025 Sep 18 @ $24.67 Raman Singh (Director), $1,174,974 -3.6% -9.0% -8.9% +37.9%
Sep 2, 2025 Sep 3 @ $29.22 Paul B Manning (Director), $18,957,475 -1.3% -6.6% -25.1% +5.4%

Aftermath: entry is the close of the first session the event was fully known (the same session for price moves, the reaction session for earnings, the next session for Reddit, analyst and insider events, which are dated by day). Repeats within a few sessions count as one event. Past performance after an event says nothing certain about the next one. Not advice.